SAN DIEGO — A talk on whether sulfonylureas still have a role in the contemporary treatment of type 2 diabetes garnered much interest here at the American Diabetes Association (ADA) 2017 Scientific ...

People with type 2 diabetes treated with metformin plus a sulfonylurea with high affinity for cardiac mitochondrial adenosine triphosphate–sensitive potassium (mitoK ATP) channels, such as glyburide ...

Neonatal diabetes can result from mutations in either Kir6.2 or SUR1 subunits of the pancreatic potassium ATP channel, which disrupt insulin release. Sulfonylureas close these channels and restore ...

Children with certain developmental delays associated with neonatal diabetes showed measurable improvement in their symptoms after switching from insulin therapy to sulfonylurea therapy for 12 months, ...

Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin. Patients taking metformin for type 2 diabetes (T2D) who switch to ...

HealthDay News — Adding a sulfonylurea or metformin to insulin is associated with approximately a 1% reduction in hemoglobin A1c (HbA1c), and addition of a sulfonylurea (but not metformin) is ...

Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...

For better glycemic control in diabetic patients, some studies recommend using the combination of NPH or insulin lispro with sulfonylurea. What is the rationale behind such combinations, given that ...

Please provide your email address to receive an email when new articles are posted on . A higher risk of coronary heart disease is associated with long-term use of sulfonylureas among women with ...

Different blood sugar medications can cause different side effects. Learn more about some of the serious possible side effects of common diabetes medications here.

The medication glyburide, which has been increasingly used to treat gestational diabetes in pregnant women, was associated with higher risk for newborns to be admitted to a neonatal intensive care ...